康泰转2

Search documents
康泰生物: 关于可转换公司债券2025年付息公告
Zheng Quan Zhi Xing· 2025-07-09 11:12
Group 1 - The company will pay the fourth-year interest of the convertible bond "Kangtai Zhuan 2" on July 15, 2025, at a rate of 1.50%, amounting to RMB 15.00 for every 10 bonds (including tax) [1][4] - The bond was issued on July 15, 2021, with a total of 20 million bonds at a face value of RMB 100 each, raising a total of RMB 200 million [2][3] - The interest payment will be made annually, with the first-year rate at 0.30%, increasing to 2.00% by the sixth year [2][3] Group 2 - The interest income tax for individual investors is subject to a 20% withholding tax, while qualified foreign institutional investors (QFII and RQFII) are exempt from corporate income tax and value-added tax [4][5] - The interest payment date is set for July 15 each year, with the record date being the trading day before the payment date [3][4] - The company will entrust China Securities Shenzhen Branch to handle the interest payment process [5]
康泰生物: 2025年第二季度可转换公司债券转股情况公告
Zheng Quan Zhi Xing· 2025-07-02 16:06
Core Points - The company announced the latest conversion price for its convertible bonds is RMB 15.73 per share [1] - The total amount of convertible bonds issued is RMB 2,000 million, with a face value of RMB 100 per bond [2] - As of June 30, 2025, the remaining convertible bonds amount to RMB 1,999,004,300, with 19,990,043 bonds still outstanding [2][3] Convertible Bond Issuance - The company issued 20 million convertible bonds on July 15, 2021, approved by the China Securities Regulatory Commission [1] - The bonds were listed on the Shenzhen Stock Exchange on August 5, 2021, under the name "康泰转2" and code "123119" [2] - The conversion period for the bonds started on January 1, 2022, and will last until the bonds mature [2] Share Capital Changes - The conversion of 650 shares occurred, reducing the number of convertible bonds by 103 [2] - The total share capital before the conversion was 1,116,927,887 shares, which increased to 1,116,928,537 shares after the conversion [3] - The proportion of restricted shares decreased from 20.69% to 19.44%, while unrestricted shares increased from 79.31% to 80.56% [3]
康泰生物: 关于可转债转股价格调整的公告
Zheng Quan Zhi Xing· 2025-05-27 11:35
Group 1 - The core point of the announcement is the adjustment of the conversion price for the company's convertible bonds "Kangtai Zhuan 2" from 15.82 CNY to 15.73 CNY per share, effective from June 6, 2025 [1][2] - The adjustment is based on the company's 2024 annual equity distribution plan, which includes a cash dividend of 0.90 CNY per 10 shares, with no stock dividends or capital reserve transfers [2] - The adjustment formula used for the conversion price is P1 = P0 - D, where P0 is the previous conversion price and D is the cash dividend per share [2] Group 2 - The company issued 20 million convertible bonds on July 15, 2021, under the code "Kangtai Zhuan 2" [1] - The adjustment of the conversion price is in accordance with relevant laws and regulations, as well as the terms outlined in the bond issuance prospectus [1][2] - The effective date for the new conversion price will be the day after the equity distribution, which is June 6, 2025 [2]
康泰生物: 2025年第一季度可转换公司债券转股情况公告
Zheng Quan Zhi Xing· 2025-04-02 09:26
Group 1 - The core point of the announcement is the update on the convertible bonds issued by Shenzhen Kangtai Biological Products Co., Ltd., including the current conversion price and the changes in the company's total share capital due to bond conversions [1][2][4] - The company issued 20 million convertible bonds with a total fundraising amount of RMB 2 billion, with a face value of RMB 100 per bond, approved by the China Securities Regulatory Commission [1][2] - The convertible bonds, named "Kangtai Zhuan 2," were listed on the Shenzhen Stock Exchange on August 5, 2021, and the current conversion price is RMB 15.82 per share [2][4] Group 2 - As of March 31, 2025, the total number of convertible bonds remaining is 19,990,146, with a remaining convertible bond amount of RMB 1,999,014,600 [2] - The company's share capital structure shows a decrease in restricted shares from 235,537,028 to 231,096,718, while unrestricted shares increased from 881,390,709 to 885,831,169, resulting in a total share capital of 1,116,927,887 shares [2][4] - The changes in share capital are attributed to the recalculation of executive lock-up shares and the automatic lock-up of shares held by newly appointed directors and executives [2][4]
3月27日投资提示:康泰转2下修到底
集思录· 2025-03-26 15:09
Core Viewpoint - The article discusses the upcoming voting deadline for holders of the SouTe convertible bond, emphasizing the importance of participation in the bankruptcy proceedings and the election of two bondholders [1]. Group 1 - The voting deadline is set for March 27 at 15:00, with only one day left for holders to cast their votes [1]. - The proposal includes electing two bondholders to participate in the bankruptcy process and obtaining the list of bondholders for further communication [1]. - Voting can be done through the China Securities Depository and Clearing Corporation's WeChat mini-program or official website, taking approximately two minutes after real-name verification [2]. Group 2 - The article mentions specific convertible bonds: Kangtai Convertible Bond is set for a downward adjustment, while Kaisheng and Xingrui Convertible Bonds will not undergo adjustments [2]. - Yonggui Convertible Bond is scheduled to be listed on March 28 [2]. - The article encourages following the Jisilu WeChat account for more updates and information [3].